ECKERD CORP
8-K, 1998-02-11
DRUG STORES AND PROPRIETARY STORES
Previous: ECHLIN INC, SC 13G, 1998-02-11
Next: ELECTROMAGNETIC SCIENCES INC, SC 13G/A, 1998-02-11



                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549




                                    FORM 8-K

                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported) - February 4, 1998



                               ECKERD CORPORATION
              (Exact name of registrant as specified in is charter)





         Delaware                      1-4844                  51-0378122

(State or other jurisdiction    (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)


   8333 Bryan Dairy Road
   Largo, Florida                                                33777

(Address of principal
  executive offices)                                           (Zip Code)


Registrant's telephone number, including area code:     (813) 395-6000





Item 5.           Other Events.
- -------           -------------

         On February 4, 1998, Eckerd Corporation (the "Company"), a wholly-owned
subsidiary of J.C. Penney Company, Inc., was served with a civil complaint which
was filed  jointly in federal  court in Tampa,  Florida by the Florida  Attorney
General,  the U.S. Department of Justice, and the U.S. Attorney's Office for the
Middle  District  of  Florida.  The  complaint  relates  to what is known in the
drugstore  industry as partial filling of prescriptions  and how they are billed
in those  relatively  limited  situations  when a customer  fails to pick up the
balance of a partially filled prescription.

         The complaint seeks triple the amount of monetary damages and penalties
up to $10,000 for each bill for a partially filled prescription.  However,  this
complaint  focuses on a very small  percentage  of  prescriptions  filled by the
Company,   and  management  is  of  the  opinion  that,  although  the  ultimate
disposition  of this suit  cannot be forecast  with  certainty,  the  litigation
should  not  have  a  material  adverse  effect  on the  Company's  consolidated
financial position or results of operations.


                                       -2-


                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                     ECKERD CORPORATION


                                                     \s\ Samuel G. Wright
                                                     ------------------------
                                                     Samuel G. Wright
                                                     Executive Vice President/
                                                     Chief Financial Officer

Date:  February 10, 1998


                                       -3-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission